SEC Tracker
Get the app

Vivos Therapeutics VVOS

Vivos Therapeutics, Inc., entered into an At The Market Offering Agreement

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 10.2
Material contract
Exhibit 10.3
Material contract
  • Signs a material agreement (1.01)
  • Reports an executive or board change (5.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Vivos Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (3841) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Allurion Technologies ALUR public float $21M, Jun 30, 2025
  2. Neuroone Medical Technologies NMTC public float $26M, Mar 31, 2025, over 18 months old
  3. RenovoRx RNXT public float $27M, Jun 30, 2025
  4. Nephros NEPH public float $27M, Jun 30, 2025
  5. DarioHealth DRIO public float $28M, Jun 30, 2025